Neonatal mitochondrial hepatoencephalopathy caused by novel GFM1 mutations

• Main Authors: Kirstine Ravn, Bitten Schönewolf-Greulich, Rikke M. Hansen, Anna-Helene Bohr, Morten Duno, Flemming Wibrand, Elsebet Ostergaard
• Format: Article
• Language: English
• Published: Elsevier 2015-06-01
• Series: Molecular Genetics and Metabolism Reports
• Subjects: EFG1 (GFM1, 606639); Neonatal mitochondrial hepatoencephalopathy; Mitochondrial disorder
• Online Access: http://www.sciencedirect.com/science/article/pii/S2214426915000063

Disorders caused by defects in the mitochondrial translation system are clinically and genetically heterogeneous. The elongation phase of mitochondrial protein synthesis requires, among many other components, three nuclear-encoded elongation factors: EFTu (TUFM; 602389), EFTs (TSFM; 604723), and EFG1 (GFM1; 606639). Mutations have been identified in the genes encoding all three elongation factors, and they result in combined respiratory chain deficiencies and severe phenotypes with an early fatal outcome. So far, only eleven patients have been reported with mutations in GFM1. Here we describe an additional three patients with novel GFM1 mutations. Our results confirm the tissue-specific effect of GFM1 mutations, since we found only slightly decreased respiratory chain enzyme activities in muscle and fibroblasts, but a severe deficiency in the liver. Hence, a thorough biochemical evaluation is important to guide genetic investigation in patients suspected for a mitochondrial disorder.